NASH question:
It was openly stated that CYDY would
NASH question:
It was openly stated that CYDY would aggressively seek a partner with NASH if the results are worthy. Given that possibility what could that potentially do for the PPS?
I’ve seen some articles about other biotechs with good phase two data and their PPS rose substantially.
Even if it were only a few dollars it would make those 200 millions shares worth much more to fund future trials etc.
I’m curious what others think about what will be the first catalyst?
Could the Brazil trial be filling up? We just haven’t gotten a PR yet?
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Everest Group's Legal Quagmire: A Rocky Road Ahead Riding high has its pitfalls. I mean just take a gander at Everest Group, Ltd. (NYSE: EG). The suits and stocks got their knickers in a twist when the company's missteps saw them landing smack dab in the middle of a shareholder class-action lawsuit. It's gloomy days, my friend, especially if you're carrying a portfolio...
Continue Reading
Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...
Continue Reading
Stockholders Left Scrambling You ever have one of those days where everything is cruising along, then bam—you hit what feels like a pothole the size of Texas? Well, that's NPK International (NYSE: NPKI) right now. Their recent revenue cut sent shareholders spiraling, and now there's a legal storm brewing, led by Levi & Korsinsky. Weather Woes Lead to Lower Earnings So,...
Continue Reading
Breaking the Fear of the Dentist's Chair There's no sugar-coating it—hitting the dental chair can feel like gearing up for a bout in the boxing ring, especially if anxiety's already taken root. But listen, it doesn't have to be that way, and that's where HelloNation's recent feature steps in. Dr. Adriane Lippian and Dr. Jim Lippian, dentists hailing from Texarkana,...
Continue Reading
From Vietnam to San Francisco: Duong's Journey The odyssey begins in the tumultuous days of 1975, when the Duong family, reeling from the fall of Saigon, fled their home country. This wasn't a round-the-corner hop; it was a leap for survival, crammed in a small boat, facing the unforgiving ocean. The documentary 'The King of Trash' transports us back to that time,...
Continue Reading
Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...
Continue Reading
Thirty Years of Empowering Athletes In the world of adaptive sports, every slam dunk and sprint finish means more than just a win; it signifies victory over barriers that many of us can't even fathom. That's the world BlazeSports America has championed for three decades now. And let me tell you, not every organization has what it takes to stick it out this long,...
Continue Reading
Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...
Continue Reading
FDA Decision: A Big Win for Reynolds American Boy, am I seeing a shift in the winds. The FDA's green light for VELO nicotine pouches adds a fresh feather to Reynolds American's cap. In a gritty industry like tobacco, getting FDA's nod ain't just about safety; it’s a strategic leg up against traditional smoke. My gut tells me this isn't just about keeping pace. It's...
Continue Reading
From Honored Beginnings to Today's Accolades Meandering down the memory lane of Texas's own A+ Federal Credit Union (A+FCU), I can't help but notice—this institution has really carved out a niche. In Austin, they're not just another bank. No, sir. For four straight years, A+FCU has been voted the #1 Credit Union in the Best of ATX Awards. Just let that simmer in your...
Continue Reading
Top 5 Most Recently Viewed Articles
America's Car-Mart Under Investor Scrutiny Recently, America's Car-Mart, Inc. (NASDAQ: CRMT) experienced a noteworthy stock decline as investors reacted to disappointing Q1 2026 financial results. The significant drop of over $8, approximately 18%, raised concerns among shareholders and prompted investigation into the company's operational strategies concerning tariff...
Continue Reading
Lands' End Achieves Significant Financial Milestones DODGEVILLE, Wis. – Lands’ End, Inc. (NASDAQ: LE) has announced its financial results for the fourth quarter and the entire fiscal year 2024, which concluded recently. This announcement follows a year characterized by steady growth and strategic innovation. Strong Performance in the Fourth Quarter During the fourth...
Continue Reading
Wegovy® Demonstrates Hepatic Benefits Beyond Weight Loss Novo Nordisk has recently unveiled intriguing findings regarding Wegovy® (semaglutide 2.4 mg) that highlight its role in enhancing liver health in adults diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), even in the context of limited weight loss. This revelation emerged from a post hoc...
Continue Reading
Measurabl Introduces Free Sustainability Software Measurabl, renowned for its sustainability data platform in real estate, has unveiled a groundbreaking free software solution. This innovative tool allows property and portfolio managers to measure, manage, and report on sustainability performance without any cost. With this recent launch, Measurabl has already registered...
Continue Reading
The Joint Corp. Showcases Remarkable Growth in 2024 Metrics - Adjustments Performed in 2024 Grows 9%, Compared to 2023 - - Receives Letters of Intent for Majority of Corporate Portfolio - SCOTTSDALE, Ariz. — The Joint Corp. (NASDAQ: JYNT), a leader in chiropractic care across the nation, has reported impressive operating metrics for the year ending 2024. The company's...
Continue Reading